Members | Australian Cardiovascular Alliance (ACvA)
To update your details or renew your membership, please click the button below:
Become a Member
Membership is open to individuals, scientific societies, institutions and organisations committed to quality cardiovascular research in Australia.
Membership fees are payable annually with membership running over the calendar year (January to December). The Membership Committee reviews all applications, before membership is granted.
Individual Membership: Individual researchers and clinicians are invited to become members.
The fee for individual members is $50 + GST which entitles the member to full website access, latest news, receipt of e-newsletters as well as details on Foundation grants and joint funding initiatives. To become a member please click on the button below.
Institutional and Industry Membership: Please contact firstname.lastname@example.org to become an Institutional member or Industry member.
Member organisations work together advocating and developing national strategies for maximising the impact of Australian cardiovascular research. The Alliance harnesses Australia’s leading national clinical and scientific societies as well as individual research institutes to present a united voice and promotes the development of strong collaborative networks between cardiovascular researchers Australia-wide.
List of Member Organisations
Australian Atherosclerosis Society
Australian NZ Society for Vascular Surgery
Australian Vascular Biology Society (AVBS)
Cardiac Society of Australia and New Zealand
Cardiovascular Disease Program, Monash Biomedicine Discovery Institute
Faculty of Medicine UNCSW
Heart, Lung and Circulation
High Blood Pressure Research Council of Australia
La Trobe University
Menzies Institute for Medical Research
NHMRC Clinical Trials Centre, the University of Sydney
South Australian Health & Medical Research Institute (SAHMRI)
The George Institute
The University of Sydney – Cardiovascular Initiative
The Victor Chang Cardiac Research Institute
Cardiovascular pharmaceutical and device companies are major players in the global biotech sector and ACvA industry members pursue goals that include the translation of evidence-based diagnostics and therapeutics to Australia in order to improve health.
Industry members support the goals of the ACvA through their membership fees, enabling the development and roll out of projects related to the mission of the ACvA. Industry members also participate in industry round table meetings with ACvA members where a bipartisan approach to common goals for the Australian public, such as improved access to quality medicines may be discussed and progressed.